表紙
市場調査レポート

ポルフィリン症 (骨髄性プロトポルフィリン症):世界の治験動向

Porphyria (Erythropoietic Protoporphyria) Global Clinical Trials Review, H2, 2015

発行 GlobalData 商品コード 340877
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.69円で換算しております。
Back to Top
ポルフィリン症 (骨髄性プロトポルフィリン症):世界の治験動向 Porphyria (Erythropoietic Protoporphyria) Global Clinical Trials Review, H2, 2015
出版日: 2015年08月31日 ページ情報: 英文 70 Pages
概要

当レポートでは、ポルフィリン症 (骨髄性プロトポルフィリン症) の治験に関する最新動向について分析しており、各地域の主要国における治験件数、治験の段階別進行状況、被験者採用の状況、有望なスポンサー、各企業や研究機関における研究の進行状況、有望な薬剤の比較といった情報をまとめています。

イントロダクション

  • ポルフィリン症 (骨髄性プロトポルフィリン症)
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数

G7諸国での治験件数:遺伝性疾患治療薬の治験におけるポルフィリン症 (骨髄性プロトポルフィリン症) の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

ポルフィリン症 (骨髄性プロトポルフィリン症) 治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Clinuvel Pharmaceuticals Limited
    • Digna Biotech, S.L.
    • Zymenex A/S
    • uniQure N.V.
    • Novartis AG
    • CPR Pharma Services Pty Ltd
    • Alnylam Pharmaceuticals, Inc.
  • 代表的な研究機関・病院の治験の概要
    • National Center for Research Resources
    • Assistance Publique - Hopitaux de Paris
    • FDA Office of Orphan Products Development
    • Guy's and St Thomas' NHS Foundation Trust
    • Mayo Clinic
    • The University of Utah
    • University of Texas at Galveston
    • University of Texas Medical Branch at Galveston
    • University of Texas Southwestern Medical Center at Dallas

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2843CTIDB

GlobalData's clinical trial report, "Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H2, 2015" provides an overview of Porphyria (Erythropoietic Protoporphyri) clinical trials scenario. This report provides top line data relating to the clinical trials on Porphyria (Erythropoietic Protoporphyri). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Porphyria (Erythropoietic Protoporphyri)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
  • Clinical Trials by G7 Countries: Proportion of Porphyria (Erythropoietic Protoporphyri) to Genetic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Porphyria (Erythropoietic Protoporphyri)
      • Jul 02, 2015: New England Journal of Medicine publishes pivotal Phase III SCENESSE studies
      • Jul 01, 2015: Treatment Reduces Symptoms in Syndrome that Causes Extreme Light Sensitivity
  • Clinical Trial Profiles
  • Clinical Trial Overview of Top Companies
    • Clinuvel Pharmaceuticals Limited
      • Clinical Trial Overview of Clinuvel Pharmaceuticals Limited
      • Digna Biotech, S.L.
      • Clinical Trial Overview of Digna Biotech, S.L.
      • Zymenex A/S
      • Clinical Trial Overview of Zymenex A/S
      • uniQure N.V.
      • Clinical Trial Overview of uniQure N.V.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • CPR Pharma Services Pty Ltd
      • Clinical Trial Overview of CPR Pharma Services Pty Ltd
      • Alnylam Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alnylam Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • FDA Office of Orphan Products Development
      • Clinical Trial Overview of FDA Office of Orphan Products Development
      • Guy's and St Thomas' NHS Foundation Trust
      • Clinical Trial Overview of Guy's and St Thomas' NHS Foundation Trust
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • The University of Utah
      • Clinical Trial Overview of The University of Utah
      • University of Texas at Galveston
      • Clinical Trial Overview of University of Texas at Galveston
      • University of Texas Medical Branch at Galveston
      • Clinical Trial Overview of University of Texas Medical Branch at Galveston
      • University of Texas Southwestern Medical Center at Dallas
      • Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Region, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Proportion of Porphyria (Erythropoietic Protoporphyri) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Clinuvel Pharmaceuticals Limited, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Digna Biotech, S.L., 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zymenex A/S, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by uniQure N.V., 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by CPR Pharma Services Pty Ltd, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by FDA Office of Orphan Products Development, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guy's and St Thomas' NHS Foundation Trust, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Utah, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas at Galveston, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Medical Branch at Galveston, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2015*

List of Figures

  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Proportion of Porphyria (Erythropoietic Protoporphyri) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Porphyria (Erythropoietic Protoporphyri) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top